scispace - formally typeset
Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

D.M. Harnois
- 01 Jan 2010 - 
- Vol. 2010, pp 233-234
About: 
This article is published in Yearbook of Gastroenterology.The article was published on 2010-01-01. It has received 584 citations till now. The article focuses on the topics: Hepatitis C virus.

read more

Citations
More filters
Journal ArticleDOI

Emerging therapies for the treatment of hepatitis C

Christian M. Lange, +3 more
- 01 Jan 2014 - 
TL;DR: Significant further improvements are on the horizon, which may well cure virtually all hepatitis C patients with an all‐oral, interferon‐free regimen in the very near future.
Journal ArticleDOI

Anti-fibrotic therapy: Lost in translation?

Detlef Schuppan, +3 more
- 01 Jan 2012 - 
TL;DR: The field is now moving more quickly towards clinical translation, driven by thoughtful preclinical validation, a better study design and improved surrogate readouts using currently available methodologies, and upcoming novel biomarkers and imaging technologies will soon permit a more exact and efficient assessment of fibrosis progression and regression.
Journal ArticleDOI

Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.

David S. Goldberg, +12 more
- 01 Mar 2017 - 
TL;DR: The responsibility for suboptimal surveillance rests with patients, providers, and the overall health care system; several measures can be implemented to potentially increase HCC surveillance, including increasing patient–specialist visits and minimizing appointment lead time.
Journal ArticleDOI

Chemoembolization for hepatocellular carcinoma.

Riccardo Lencioni
- 01 Aug 2012 - 
TL;DR: Data from a large phase II randomized, double-blind, placebo-controlled trial have shown that the concurrent administration of DEB-TACE and sorafenib has a manageable safety profile and suggested that time to progression and time to vascular invasion or extrahepatic spread may be improved with respect to DEB -TACE alone.
Journal ArticleDOI

Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment.

Eiichi Ogawa, +14 more
- 01 Jan 2018 - 
TL;DR: With the development of direct‐acting anti‐virals (DAAs), almost all patients with chronic hepatitis C virus (HCV) infection can achieve sustained viral response (SVR).
References
More filters
Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

Gary L. Davis, +4 more
- 01 Feb 2010 - 
TL;DR: Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.
Related Papers (5)

The Epidemiology of Chronic Hepatitis C and One-Time Hepatitis C Virus Testing of Persons Born During 1945 to 1965 in the United States

John W. Ward
- 01 Feb 2013 - 

Hepatitis C virus infection in HIV-infected patients

Mark S. Sulkowski
- 01 Oct 2001 - 

Epidemiology of hepatitis C virus in japan.

Takashi Moriya, +4 more
- 10 Sep 1999 - 

Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates.

Fernando Herz Wolff, +11 more
- 05 May 2010 - 

Human immunodeficiency virus/hepatits C virus coinfection in Spain: elimination Is feasible, but the burden of residual cirrhosis will be significant

Juan Berenguer, +46 more
- 01 Jan 2018 -